This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Saint Louis University to Launch Human Zika Vaccine Trial
    Saint Louis University’s vaccine center has been tapped by the National Institutes of Health to conduct a human clinical trial of a vaccine to prevent the Zika virus, which can cause devastating birth defects in babies. ...More
    Yesterday Posted in News
  • Drones Could be Cheaper Alternative to Delivering Vaccines in the Developing World
    Using unmanned drones to deliver vaccines in low- and middle-income countries may save money and improve vaccination rates, new research led by the Johns Hopkins Bloomberg School of Public Health and the Pittsburgh Supercomputing Center suggests. The cost savings would come ...More
    4 days ago Posted in News
  • FDA Approves Vaccine to Prevent Cholera in Travelers
    The Food and Drug Administration (FDA) announces that it has approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the ...More
    2 weeks ago Posted in News
  • Pneumococcal Vaccine 'Watches' Bacteria, Strikes Only When Needed
    A new vaccine allows pneumonia-causing bacteria to colonize inside the body, springing into action only if the bacteria pose a threat.  The breakthrough approach, coupled with the protein-based vaccine's potential to counteract more than 90 strains of the bacteria, has ...More
    3 weeks ago Posted in News
  • Reported Data on Vaccines May Not Build Public Trust or Adherence
    The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety reporting system that collects information about possible side effects that may occur after inoculation. Developed by the Centers for Disease Control (CDC) and available online, anyone can ...More
    4 weeks ago Posted in News
  • Gaps in Vaccine Coverage Highlighted by New Report and Online Tool
    As the 69th World Health Assembly discusses progress on the Global Vaccine Action Plan, a new data visualization platform from the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) provides stark numbers on where ...More
    May 24, 2016 Posted in News
  • Putting the Brakes on Cell's 'Engine' Could Give Flu and Other Vaccines a Boost
    A relatively unknown molecule that regulates metabolism could be the key to boosting an individual's immunity to the flu -- and potentially other viruses -- according to research reported today in the journal Immunity. The study, led by University of Vermont (UVM) College ...More
    May 24, 2016 Posted in News
  • New Strategy Could Yield More Precise Seasonal Flu Vaccine
    During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective. While this year’s vaccine is a much better match to the ...More
    May 23, 2016 Posted in News
  • Zika Virus Protein Could Be Vaccine Target
    A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health (NIH) scientists and colleagues at Mount Sinai's Icahn School of Medicine. Their study, published online May 19, 2016 in Cell Host ...More
    May 19, 2016 Posted in News
  • Large-Scale HIV Vaccine Trial to Launch in South Africa
    An early-stage HIV vaccine clinical trial in South Africa has determined that an investigational vaccine regimen is safe and generates comparable immune responses to those reported in a landmark 2009 study showing that a vaccine can protect people from HIV infection. ...More
    May 19, 2016 Posted in News
« Previous1234567891011115116Next »